Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

Join our team for an expert debrief from ASCO® 2026. With a front-row seat across multiple client engagements, we’ll share the scientific highlights, attendee perspectives and strategic lessons from one of oncology’s most important annual gatherings, while exploring what smarter, more measurable congress engagement looks like in practice.
What we’ll cover
The experts shaping the conversation
This content was provided by Inizio
Latest Content from Inizio
Published in eye for pharma 3 April by Marc Yates
Published in Medical Marketing & Media March 2015
Dr Allison Fleetwood, Director of Therapy Watch, alongside Associate Director Jennifer Redfearn, recently delivered a workshop on measuring and tracking brand KPIs as part of the BHBIA training programme (www.bhbia.org.uk).
View from the US: When I talk to family members or friends who are physicians these days, I hear a lot of complaints.
I want to write today about 2 men that between them have reminded me of a fine line that we have to tread every time we analyse a dataset…
My recent article in Medical Marketing & Media explored the importance of vaccine perceptions in a self-pay market and touched upon the issue of stigma, with the recognition that some diseases or…
One thing that grasps my interest is how society has adopted military style language when talking about cancer
In 2001, British economist Jim O’Neill coined the now ubiquitous acronym ‘BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, which he suggested were all…
As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.
Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.
